These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11181670)

  • 21. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.
    Ardizzoni A; Boni L; Tiseo M; Fossella FV; Schiller JH; Paesmans M; Radosavljevic D; Paccagnella A; Zatloukal P; Mazzanti P; Bisset D; Rosell R;
    J Natl Cancer Inst; 2007 Jun; 99(11):847-57. PubMed ID: 17551145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer.
    Ganti AK; Williams CD; Gajra A; Kelley MJ
    Cancer; 2015 Aug; 121(15):2578-85. PubMed ID: 25873330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxel.
    Di Maio M; Krzakowski M; Fougeray R; Kowalski DM; Gridelli C
    Lung Cancer; 2012 Jul; 77(1):116-20. PubMed ID: 22361218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.
    Douillard JY; Tribodet H; Aubert D; Shepherd FA; Rosell R; Ding K; Veillard AS; Seymour L; Le Chevalier T; Spiro S; Stephens R; Pignon JP;
    J Thorac Oncol; 2010 Feb; 5(2):220-8. PubMed ID: 20027124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II trial of gefitinib monotherapy in chemotherapy-naïve patients of 75 years or older with advanced non-small cell lung cancer.
    Ebi N; Semba H; Tokunaga SJ; Takayama K; Wataya H; Kuraki T; Yamamoto H; Akamine SJ; Okamoto I; Nakanishi Y;
    J Thorac Oncol; 2008 Oct; 3(10):1166-71. PubMed ID: 18827614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).
    Belani CP; Fossella F
    Cancer; 2005 Dec; 104(12):2766-74. PubMed ID: 16288485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients.
    Chang GC; Tsai CM; Chen KC; Yu CJ; Shih JY; Yang TY; Lin CP; Hsu JY; Chiu CH; Perng RP; Yang PC; Yang CH
    J Thorac Oncol; 2006 Jul; 1(6):520-5. PubMed ID: 17409911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Referral patterns in advanced non-small cell lung cancer: impact on delivery of treatment and survival in a contemporary population based cohort.
    Noonan K; Tong KM; Laskin J; Melosky B; Sun S; Murray N; Ho C
    Lung Cancer; 2014 Dec; 86(3):344-9. PubMed ID: 25439436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective analysis comparing the safety and efficacy of chemotherapy in elderly and non-elderly non-small-cell lung cancer patients.
    Tsubata Y; Honda T; Okimoto T; Miura K; Karino F; Iwamoto S; Suzuki T; Hamaguchi S; Kanda H; Sutani A; Kuraki T; Isobe T
    Geriatr Gerontol Int; 2012 Jul; 12(3):499-505. PubMed ID: 22233257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
    Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
    J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes in elderly patients with advanced non-small cell lung cancer: results from ARIES, a bevacizumab observational cohort study.
    Wozniak AJ; Kosty MP; Jahanzeb M; Brahmer JR; Spigel DR; Leon L; Fish S; Flick ED; Hazard SJ; Lynch TJ
    Clin Oncol (R Coll Radiol); 2015 Apr; 27(4):187-96. PubMed ID: 25576353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer.
    Williams CD; Gajra A; Ganti AK; Kelley MJ
    Cancer; 2014 Jul; 120(13):1939-47. PubMed ID: 24668613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.
    Corso CD; Rutter CE; Park HS; Lester-Coll NH; Kim AW; Wilson LD; Husain ZA; Lilenbaum RC; Yu JB; Decker RH
    J Clin Oncol; 2015 Dec; 33(36):4240-6. PubMed ID: 26481366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease.
    Sigel K; Mhango G; Cohen J; Halm EA; Mandeli J; Strauss G; Wisnivesky J
    Ann Surg Oncol; 2013 Mar; 20(3):1013-9. PubMed ID: 23115004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
    Kris MG; Natale RB; Herbst RS; Lynch TJ; Prager D; Belani CP; Schiller JH; Kelly K; Spiridonidis H; Sandler A; Albain KS; Cella D; Wolf MK; Averbuch SD; Ochs JJ; Kay AC
    JAMA; 2003 Oct; 290(16):2149-58. PubMed ID: 14570950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pemetrexed therapy in elderly patients with good performance status: analysis of two phase III trials of patients with nonsquamous non-small-cell lung cancer.
    Gridelli C; Brodowicz T; Langer CJ; Peterson P; Islam M; Guba SC; Moore P; Visseren-Grul CM; Scagliotti G
    Clin Lung Cancer; 2012 Sep; 13(5):340-6. PubMed ID: 22266043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
    Aarts MJ; van den Borne BE; Biesma B; Kloover JS; Aerts JG; Lemmens VE
    Int J Cancer; 2015 Mar; 136(5):E387-95. PubMed ID: 25219898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort study.
    Lynch TJ; Spigel DR; Brahmer J; Fischbach N; Garst J; Jahanzeb M; Kumar P; Vidaver RM; Wozniak AJ; Fish S; Flick ED; Leon L; Hazard SJ; Kosty MP;
    J Thorac Oncol; 2014 Sep; 9(9):1332-9. PubMed ID: 25122429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.